Quantum-Si Issues Inducement Grants Under Nasdaq Rule 5635(c)(4)
Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), a proteomics technology company redefining protein analysis through single-molecule detection, today announced that…
Promega Presents Breakthrough Cellular Target Engagement Platform at SLAS 2026
Promega Unveils Cellular Target Engagement Technology Aimed at Expanding the Druggable Proteome at SLAS 2026 Promega Corporation is launching a new live-cell target engagement platform that could close a long-standing gap…
Arintra Slashes Coding Expenses and Achieves Strong Retention with 8X Revenue Expansion
Arintra Cuts Coding Costs by Nearly One-Third for Customers, Driving Industry-Leading Retention and 8X Revenue Growth Arintra, the leading GenAI-native autonomous medical coding platform for healthcare organizations, today announced it…
Corazon, Columbia HeartSource Introduce First-of-Its-Kind Open-Heart Surgery Accreditation
Corazon and Columbia HeartSource Announce Partnership Offering First-of-its-Kind Open-Heart Surgery Accreditation Columbia HeartSource, an extension of Columbia University Irving Medical Center’s Department of Surgery and Division of Cardiology and Corazon, a…
RxERP, p-Chip Corporation Partner on Licensing Agreement to Support DSCSA Compliance
RxERP and p‑Chip Corporation Announce Licensing Agreement to Enable Embedded Unit‑Level Digital Identity for DSCSA Compliance and End‑to‑End Pharmaceutical Traceability RxERP, a cloud-hosted, pharmaceutical-first ERP platform, and p‑Chip Corporation (“p‑Chip”),…
Australian Breast Cancer Innovators Secure $27M in Private Funding Round
Australian Breast Cancer Innovators Close $27M Private Funding Round OncoRes Medical today announced it has closed an AUD $27M private funding round (‘the Funding round’) to progress clinical development and…
KalVista Pharmaceuticals Showcases EKTERLY® Data at AAAAI 2026 Annual Meeting
KalVista Pharmaceuticals to Present EKTERLY® (sebetralstat) Data at the 2026 American Academy of Allergy, Asthma & Immunology Annual Meeting KalVista Pharmaceuticals, Inc. today announced the acceptance of three abstracts for presentation at…
iProov Dynamic Liveness Sets Industry First with Top Injection Attack Detection Certifications
iProov Dynamic Liveness Is the First and Only Solution to Achieve CEN/TS 18099 High and Ingenium Level 4 for Injection Attack Detection iProov, the world’s leading provider of science-based biometric…
Galderma Introduces First-of-Its-Kind “We Are All Sculptra” Campaign Showcasing Treatment Benefits
We Are All Sculptra: First-of-its-Kind Galderma Initiative to Demonstrate How Everyone Can Benefit from Sculptra’s Regenerative Properties Galderma the pure-play dermatology category leader, today unveiled We Are All Sculptra, a unique…
AHF Warns Florida Health Department Proposal Could Reduce HIV Drug Access for Thousands
Florida Health Dept. Proposes New Formal Rule to Slash HIV Drug Access for Thousands, Notes AHF The Florida Department of Health (DOH) today published its Notice of Proposed Rule to formally implement…
Loyal Secures $100M Series C Funding to Advance Development of First Canine Longevity Drug
Loyal Raises $100M Series C, Led by age1, to Advance the First Canine Longevity Drug Loyal, a clinical-stage animal health company developing lifespan extension drugs for dogs, announced today that…
Natus Sensory Acquires TheraB Medical to Advance Neonatal Phototherapy Innovation
Natus Sensory Acquires TheraB Medical to Expand Innovation in Neonatal Phototherapy Natus Sensory, a global leader in sensory and newborn care solutions, today announced the acquisition of TheraB Medical, a…